Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Wei Lun Lo"'
Autor:
Chun-Wei Wu, Bor-Shing Lin, Zhao Zhang, Tsung-Hsun Hsieh, Jian-Chiun Liou, Wei-Lun Lo, Yu-Ting Li, Shao-Chu Chiu, Chih-Wei Peng
Publikováno v:
Journal of NeuroEngineering and Rehabilitation, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Transcranial temporal interference stimulation (tTIS) is a promising brain stimulation method that can target deep brain regions by delivering an interfering current from surface electrodes. Most instances of tTIS stimulate the brain with a
Externí odkaz:
https://doaj.org/article/842557d2dffe461886dd02a7c9aa2415
Autor:
Po-Wei Huang, Syu-Jyun Peng, David Hung-Chi Pan, Huai-Che Yang, Jo-Ting Tsai, Cheng-Ying Shiau, I-Chang Su, Ching-Jen Chen, Hsiu-Mei Wu, Chung-Jung Lin, Wen-Yuh Chung, Wan-Yuo Guo, Wei-Lun Lo, Shao-Wen Lai, Cheng-Chia Lee
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The aim of the study was to investigate whether morphology (i.e. compact/diffuse) of brain arteriovenous malformations (bAVMs) correlates with the incidence of hemorrhagic events in patients receiving Stereotactic Radiosurgery (SRS) for unru
Externí odkaz:
https://doaj.org/article/3822602701c44faf9b39e2a80b3c555e
Autor:
Yu-Ting Tsai, Wei-Lun Lo, Pin-Yuan Chen, Chiung-Yuan Ko, Jian-Ying Chuang, Tzu-Jen Kao, Wen-Bing Yang, Kwang-Yu Chang, Chia-Yang Hung, Ushio Kikkawa, Wen-Chang Chang, Tsung-I. Hsu
Publikováno v:
Journal of Biomedical Science, Vol 29, Iss 1, Pp 1-17 (2022)
Abstract Background Sp1 is involved in the recurrence of glioblastoma (GBM) due to the acquirement of resistance to temozolomide (TMZ). Particularly, the role of Sp1 in metabolic reprogramming for drug resistance remains unknown. Methods RNA-Seq and
Externí odkaz:
https://doaj.org/article/41e5eb2931d64c3ea1398dfe091319be
Publikováno v:
NBER Working Papers; Aug2024, Issue 32785-32859, p1-47, 73p
Autor:
Wen-Bin Yang, An-Chih Wu, Tsung-I Hsu, Jing-Ping Liou, Wei-Lun Lo, Kwang-Yu Chang, Pin-Yuan Chen, Ushio Kikkawa, Shung-Tai Yang, Tzu-Jen Kao, Ruei-Ming Chen, Wen-Chang Chang, Chiung-Yuan Ko, Jian-Ying Chuang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 10, Pp 1-13 (2021)
Abstract DNA repair promotes the progression and recurrence of glioblastoma (GBM). However, there remain no effective therapies for targeting the DNA damage response and repair (DDR) pathway in the clinical setting. Thus, we aimed to conduct a compre
Externí odkaz:
https://doaj.org/article/0550dd11627c4cb1b510f29cabb3b452
Autor:
Chia-Hung Chien, Jian-Ying Chuang, Shun-Tai Yang, Wen-Bin Yang, Pin-Yuan Chen, Tsung-I Hsu, Chih-Yuan Huang, Wei-Lun Lo, Ka-Yen Yang, Ming-Sheng Liu, Jui-Mei Chu, Pei-Hsuan Chung, Jr-Jiun Liu, Shao-Wen Chou, Shang-Hung Chen, Kwang-Yu Chang
Publikováno v:
Journal of Biomedical Science, Vol 26, Iss 1, Pp 1-16 (2019)
Abstract Background Intratumor subsets with tumor-initiating features in glioblastoma are likely to survive treatment. Our goal is to identify the key factor in the process by which cells develop temozolomide (TMZ) resistance. Methods Resistant cell
Externí odkaz:
https://doaj.org/article/a4d420e0b4e94a6d81430e61fa42269e
Autor:
Ching‐Yu Lin, Shun‐Tai Yang, Shing‐Chuan Shen, Yi‐Chen Hsieh, Fei‐Ting Hsu, Cheng‐Yu Chen, Yung‐Hsiao Chiang, Jian‐Ying Chuang, Kai‐Yun Chen, Tsung‐I Hsu, Wan‐Chong Leong, Yu‐Kai Su, Wei‐Lun Lo, Yi‐Shian Yeh, Yudha Nur Patria, Hsiu‐Ming Shih, Che‐Chang Chang, Szu‐Yi Chou
Publikováno v:
Molecular Oncology, Vol 12, Iss 5, Pp 756-771 (2018)
Glioblastoma multiforme (GBM) is a highly malignant type of brain tumor found in humans. GBM cells reproduce quickly, and the median survival time for patients after therapy is approximately 1 year with a high relapse rate. Current therapies and diag
Externí odkaz:
https://doaj.org/article/bc535ccfd9814d4ca341a341e8391a1e
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11, p 5557 (2021)
Glioblastoma multiforme (GBM) has remained one of the most lethal and challenging cancers to treat. Previous studies have shown encouraging results when irinotecan was used in combination with temozolomide (TMZ) for treating GBM. However, irinotecan
Externí odkaz:
https://doaj.org/article/3554fb60a2e04abd8d20265cd4bf200b
Publikováno v:
Parkinsonism & Related Disorders. :105431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27e27572ab854188a9e9f86bd5ad7bd8
https://doi.org/10.1016/j.parkreldis.2023.105431
https://doi.org/10.1016/j.parkreldis.2023.105431
Autor:
Wei-Lun Lo
Publikováno v:
WFNOS 2022 Abstract Book.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::302bc5ac5f111603613317cd6e0e3734
https://doi.org/10.14791/btrt.2022.10.f-1197
https://doi.org/10.14791/btrt.2022.10.f-1197